South Africa halts AstraZeneca vaccine rollout over new variant

South Africa has put its rollout of the Oxford-AstraZeneca vaccine on hold after a study showed "disappointing" results against its new Covid variant.

Scientists say the variant accounts for 90% of new Covid cases in South Africa.